Clinical Updates
FDA Approves New Migraine Treatments
Two new medications for the treatment of acute migraine with or without aura in adults…
FDA Releases Warning Regarding Gabapentin and Pregabalin
The FDA recently released a warning for the medications, gabapentin (Neurontin, Gralise, Horizant) and pregabalin…
FDA Alert Concerning Ranitidine Products
By: Heidi Dufrene, Pharmacy Director Earlier this month, the U.S. Food and Drug Administration (FDA)…
The U.S. DEA Proposes Production Cuts to Five Opioids in 2020
The U.S. DEA (Drug Enforcement Administration) released a Notice of Proposed Rulemaking in the Federal…
Generic Launch of Rozerem
The generic equivalent of Rozerem (Ramelteon) is now available. Rozerem is FDA approved for the…
Launch of Generic Lyrica
The U.S. Food and Drug Administration (FDA) has approved the launch of generic Lyrica (pregabalin)….
Gabapentin to Become A Controlled Substance in Alabama
By: Heidi Dufrene, PharmD Recently, the Alabama State Committee of Public Health voted to…
Gabapentin to Become a Controlled Substance in Virginia
The 2019 Virginia General Assembly recently passed a new bill that will classify gabapentin as…
Launch of Generic Proventil HFA
The generic equivalent of Proventil HFA (Albuterol HFA) is now available. Proventil HFA is FDA…
Launch of Generic Vesicare
By: Heidi Dufrene, PharmD The generic equivalent of Vesicare (Solifenacin succinate) is now available. Vesicare…
